NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+10.44%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.19B
AUM Growth
+$1.19B
(+19%)
Cap. Flow
+$55.1M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
45.75%
Holding
138
New
15
Increased
34
Reduced
25
Closed
7
Top Buys
| 1 |
Titan Machinery
TITN
|
$22.6M |
| 2 |
Fulcrum Therapeutics
FULC
|
$17.1M |
| 3 |
The Bancorp
TBBK
|
$13.4M |
| 4 |
PWSC
PowerSchool Holdings, Inc.
PWSC
|
$13.3M |
| 5 |
BlackSky Technology
BKSY
|
$11.6M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$18.3M |
| 2 |
Bioventus
BVS
|
$11.8M |
| 3 |
IMAX
IMAX
|
$10.7M |
| 4 |
Instil Bio
TIL
|
$7.2M |
| 5 |
Establishment Labs
ESTA
|
$6.65M |
Sector Composition
| 1 | Healthcare | 68.55% |
| 2 | Consumer Discretionary | 10.79% |
| 3 | Communication Services | 5.34% |
| 4 | Financials | 5.01% |
| 5 | Industrials | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ocular Therapeutix
OCUL
$2.12B
| $6.09M | 0.31% | 700,000 -300,000 | -30% | -$2.61M |
|
52
Eton Pharmaceutcials
ETON
$464M
| $5.99M | 0.3% | 998,733 +58,000 | +6% | +$348K |
|
53
InspireMD
NSPR
$102M
| $5.92M | 0.3% | 2,209,593 +182,993 | +9% | +$490K |
|
54
Cellectar Biosciences
CLRB
$15.5M
| $5.8M | 0.29% | 2,712,443 +879,118 | +48% | +$1.88M |
|
55
Alta Equipment Group
ALTG
$267M
| $5.7M | 0.29% | 845,115 +6,893 | +0.8% | +$46.5K |
|
56
NN Inc
NNBR
$129M
| $5.69M | 0.29% | 1,458,416 +1,970 | +0.1% | +$7.68K |
|
57
Noodles & Co
NDLS
$33.1M
| $5.41M | 0.27% | 4,508,329 +200,000 | +5% | +$240K |
|
|
ILPT
58
Industrial Logistics Properties Trust
ILPT
$409M
| $5.38M | 0.27% | 1,131,132 -738,821 | -40% | -$3.52M |
|
59
Luxfer Holdings
LXFR
$359M
| $5.36M | 0.27% | 413,950 -190,193 | -31% | -$2.46M |
|
60
Nektar Therapeutics
NKTR
$568M
| $5.34M | 0.27% | 4,110,000 | – | – |
|
61
Reading International Class A
RDI
$35.1M
| $5.28M | 0.27% | 3,236,497 -8,076 | -0.2% | -$13.2K |
|
62
TELA Bio
TELA
$70.5M
| $4.85M | 0.25% | 1,915,126 -530,541 | -22% | -$1.34M |
|
63
VistaGen Therapeutics
VTGN
$102M
| $4.57M | 0.23% | 1,517,696 | – | – |
|
64
Amylyx Pharmaceuticals
AMLX
$836M
| $4.55M | 0.23% | +1,404,564 | New | +$4.55M |
|
65
Gaia
GAIA
$143M
| $4.46M | 0.23% | 915,029 | – | – |
|
66
DHI Group
DHX
$132M
| $4.31M | 0.22% | 2,376,606 +310,189 | +15% | +$563K |
|
67
Neuropace
NPCE
$303M
| $4.24M | 0.21% | 607,890 -8,933 | -1% | -$62.3K |
|
68
Zynex
ZYXI
$49.7M
| $4M | 0.2% | 490,000 | – | – |
|
69
Context Therapeutics
CNTX
$75.4M
| $3.79M | 0.19% | 1,935,484 | – | – |
|
|
SLN
70
Silence Therapeutics
SLN
$227M
| $3.64M | 0.18% | 200,000 | – | – |
|
71
Lexicon Pharmaceuticals
LXRX
$400M
| $3.62M | 0.18% | 2,304,150 | – | – |
|
|
BCOV
72
DELISTED
Brightcove, Inc.
BCOV
| $3.6M | 0.18% | 1,664,768 +351,000 | +27% | +$758K |
|
73
scPharmaceuticals
SCPH
$295M
| $3.42M | 0.17% | +750,000 | New | +$3.42M |
|
74
Gogo Inc
GOGO
$1.47B
| $3.41M | 0.17% | +475,497 | New | +$3.41M |
|
|
THTX
75
Theratechnologies
THTX
$149M
| $3.33M | 0.17% | 2,682,228 | – | – |
|